JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib
Crossref DOI link: https://doi.org/10.1007/s00277-015-2454-4
Published Online: 2015-07-23
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koehler, Anne
Hubert, Karolin
Lange, Thoralf
Siebolts, Udo
Wickenhauser, Claudia
Gopalakrishna, Prashanth
Niederwieser, Dietger
Monecke, Astrid
Al-Ali, Haifa Kathrin
Text and Data Mining valid from 2015-07-23